A NEW DERIVATIVE OF 1,4-BENZOTIAZEPINE-1,1-DIOXIDE WITH IMPROVED PROPERTIES, METHOD FOR ITS PRODUCTION, MEDICINE CONTAINING THE INDICATED COMPOUND AND ITS APPLICATION

摘要

1. The compound of formula A! ! and its pharmaceutically acceptable salts. ! 2. A drug containing a compound according to claim 1, to normalize lipid metabolism. ! 3. A drug containing a compound according to claim 1 and at least one additional biologically active substance, to normalize lipid metabolism. ! 4. The drug according to claim 3, characterized in that as an additional biologically active substance, it contains one or more compounds that normalize lipid metabolism. ! 5. The drug according to claim 3 or 4, characterized in that as an additional biologically active substance it contains one or more antidiabetic agents, hypoglycemic agents, anti-obesity drugs, appetite suppressants, HMGCoA reductase inhibitors, cholesterol resorption inhibitors , PPAR gamma agonists, PPAR alpha agonists, PPAR alpha / gamma agonists, fibrates, MTP inhibitors, CETP inhibitors, polymeric bile acid adsorbers, pathogens of LDL receptors, ACAT inhibitors, antioxidants, in lipoprotein lipase inhibitors, ATP-citrate lyase inhibitors, squalene synthetase inhibitors, lipoprotein (s) antagonists, lipase inhibitors, insulin, sulfonylureas, biguanides, meglitinides, thiazolidinediones, alpha-glucosidase-dependent, biologically active channel-dependent, biologically active cells, biologically active substances CART agonists, NPY agonists, cannabinoid receptor 1 antagonists, MCH receptor antagonists, MC4 agonists, orexin agonists, H3 agonists, TNF agonists, CRF agonists, CRF BP antagonists, GLP-1 derivatives, agonist urocortin ov, β3 agonists, MSH (chalk